Ipsen: raises targets for 2020.

(CercleFinance.com) - Ipsen has increased its financial targets identified for 2020, taking into account recent acquisitions, the new definition of operating profit from its businesses, and the strong performance of the business of the specialty medicine over the last 15 months.


The group now targets sales of over 2.5 billion euros, with annual growth of over 14% 2016-2020 in specialty medicine and between 4% and 6% in family health, as well as an operating margin from activities exceeding 30%.

The pharmaceutical laboratory has also announced its new strategy at an investor day in which the management team will present a comprehensive review of its business, strategy and its prospects.


Copyright (c) 2017 CercleFinance.com. All rights reserved.